THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK?

THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK?

Bibliografische gegevens
Hoofdauteurs: Craig, SE, Kohler, M, Nicoll, D, Bretton, D, Nunn, A, Davies, R, Stradling, JR
Formaat: Conference item
Gepubliceerd in: 2010

Gelijkaardige items